ANGO logoANGO
Angiodynamic Inc

966
Loading...
Loading...
News
all
press releases
Why Is Penumbra (PEN) Up 5% Since Last Earnings Report?
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·9d ago
News Placeholder
More News
News Placeholder
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO benefits from NanoKnife, clinical milestones, and a balanced portfolio despite tariff headwinds.
Zacks·15d ago
News Placeholder
ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines
AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.
Zacks·2mo ago
News Placeholder
AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) delivered earnings and revenue surprises of +76.92% and +7.52%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System
Smith + Nephew launches TRIGEN MAX, the only tibia nailing system with side-specific nails for precise, low-impact fracture repair.
Zacks·2mo ago
News Placeholder
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
Zacks·2mo ago
News Placeholder
Smith+Nephew Stock May Gain From Strategic Deal With Standard Health
Zacks·3mo ago
News Placeholder
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
Zacks·3mo ago
News Placeholder
GE HealthCare Stock Slips Despite the Launch of bkActiv S Series
Zacks·3mo ago
News Placeholder
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
Zacks·3mo ago

Latest ANGO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.